Cargando…
Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease
BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934411/ https://www.ncbi.nlm.nih.gov/pubmed/33663396 http://dx.doi.org/10.1186/s12872-021-01926-6 |
_version_ | 1783660809205841920 |
---|---|
author | Bening, C. Sales, V. L. Alhussini, K. Radakovic, D. Benitez, R. Cris Madrahimov, N. Keller, D. Leyh, R. |
author_facet | Bening, C. Sales, V. L. Alhussini, K. Radakovic, D. Benitez, R. Cris Madrahimov, N. Keller, D. Leyh, R. |
author_sort | Bening, C. |
collection | PubMed |
description | BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as well as altered levels of biomarkers might predict inapparent right ventricular dysfunction. METHODS: From 08/2016 to 02/2018, 218 patients scheduled for CABG were divided into two groups (TAPSE ≥ 20 mm, n = 178; TAPSE < 20 mm, n = 40). Baseline serum samples for biomarkers (Galectin, TGFß1, N Acyl-SDMA, Arginine, ADMA and Pentraxin-3), clinical laboratory and transthoracic echocardiographic parameters were evaluated. To examine the myocardial apparatus of the right ventricle intraoperative right auricular tissue was harvested for stepwise skinned fiber force measurements. RESULTS: Patients with TAPSE < 20 mm had a higher incidence of DM (55 vs. 34%, p = 0.018), preoperative AFib (43 vs. 16%, p < 0.001), reduced GFR (67 ± 18 vs. 77 ± 24 ml/min/1.73 m(2), p = 0.013), larger LA area (22 ± 6 vs. 20 ± 5 cm(2), p = 0.005) and reduced LVEF (50 vs. 55%, p = 0.008). Furthermore, higher serum ADMA (0.70 ± 0.13 vs. 0.65 ± 0.15 µmol/l, p = 0.046) and higher serum Pentraxin-3 levels (3371 ± 1068 vs. 2681 ± 1353 pg/dl, p = 0.004) were observed in these patients. Skinned fiber force measurements showed significant lower values at almost every step of calcium concentration (pCa 4.52 to pCa 5.5, p < 0.01 and pCa 5.75–6.0, p < 0.05). Multivariable analysis revealed DM (OR 2.53, CI 1.12–5.73, Euro Score II (OR 1.34, CI 1.02–1.78), preoperative AF (OR 4.86, CI 2.06–11.47), GFR (OR 7.72, CI 1.87–31.96), albumin (OR 1.56, CI 0.52–2.60), Pentraxin-3 (OR 19.68, CI 14.13–25.24), depressed LVEF (OR 8.61, CI 6.37–10.86), lower force values: (pCa 5.4; OR 2.34, CI 0.40–4.29 and pCa 5.2; OR 2.00, CI 0.39–3.60) as predictors for clinical inapparent right heart dysfunction. CONCLUSIONS: These preliminary data showed that inapparent right heart dysfunction in CAD is already associated with reduced force development of the contractile apparatus. |
format | Online Article Text |
id | pubmed-7934411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79344112021-03-08 Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease Bening, C. Sales, V. L. Alhussini, K. Radakovic, D. Benitez, R. Cris Madrahimov, N. Keller, D. Leyh, R. BMC Cardiovasc Disord Research Article BACKGROUND: Right ventricular dysfunction after CABG is associated with poor peri- and postoperative outcomes. We aimed to identify clinical and experimental predictors for preoperative inapparent right ventricular dysfunction and therefore hypothesized that reduced myofilament force development as well as altered levels of biomarkers might predict inapparent right ventricular dysfunction. METHODS: From 08/2016 to 02/2018, 218 patients scheduled for CABG were divided into two groups (TAPSE ≥ 20 mm, n = 178; TAPSE < 20 mm, n = 40). Baseline serum samples for biomarkers (Galectin, TGFß1, N Acyl-SDMA, Arginine, ADMA and Pentraxin-3), clinical laboratory and transthoracic echocardiographic parameters were evaluated. To examine the myocardial apparatus of the right ventricle intraoperative right auricular tissue was harvested for stepwise skinned fiber force measurements. RESULTS: Patients with TAPSE < 20 mm had a higher incidence of DM (55 vs. 34%, p = 0.018), preoperative AFib (43 vs. 16%, p < 0.001), reduced GFR (67 ± 18 vs. 77 ± 24 ml/min/1.73 m(2), p = 0.013), larger LA area (22 ± 6 vs. 20 ± 5 cm(2), p = 0.005) and reduced LVEF (50 vs. 55%, p = 0.008). Furthermore, higher serum ADMA (0.70 ± 0.13 vs. 0.65 ± 0.15 µmol/l, p = 0.046) and higher serum Pentraxin-3 levels (3371 ± 1068 vs. 2681 ± 1353 pg/dl, p = 0.004) were observed in these patients. Skinned fiber force measurements showed significant lower values at almost every step of calcium concentration (pCa 4.52 to pCa 5.5, p < 0.01 and pCa 5.75–6.0, p < 0.05). Multivariable analysis revealed DM (OR 2.53, CI 1.12–5.73, Euro Score II (OR 1.34, CI 1.02–1.78), preoperative AF (OR 4.86, CI 2.06–11.47), GFR (OR 7.72, CI 1.87–31.96), albumin (OR 1.56, CI 0.52–2.60), Pentraxin-3 (OR 19.68, CI 14.13–25.24), depressed LVEF (OR 8.61, CI 6.37–10.86), lower force values: (pCa 5.4; OR 2.34, CI 0.40–4.29 and pCa 5.2; OR 2.00, CI 0.39–3.60) as predictors for clinical inapparent right heart dysfunction. CONCLUSIONS: These preliminary data showed that inapparent right heart dysfunction in CAD is already associated with reduced force development of the contractile apparatus. BioMed Central 2021-03-05 /pmc/articles/PMC7934411/ /pubmed/33663396 http://dx.doi.org/10.1186/s12872-021-01926-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Bening, C. Sales, V. L. Alhussini, K. Radakovic, D. Benitez, R. Cris Madrahimov, N. Keller, D. Leyh, R. Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title | Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title_full | Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title_fullStr | Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title_full_unstemmed | Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title_short | Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
title_sort | clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934411/ https://www.ncbi.nlm.nih.gov/pubmed/33663396 http://dx.doi.org/10.1186/s12872-021-01926-6 |
work_keys_str_mv | AT beningc clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT salesvl clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT alhussinik clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT radakovicd clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT benitezrcris clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT madrahimovn clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT kellerd clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease AT leyhr clinicallyinapparentrightheartdysfunctionisassociatedwithreducedmyofilamentforcedevelopmentincoronaryarterydisease |